Intravenous Neonatal Central Access Safety Trial

Recruiting now · Not applicable

Conditions studied: Newborn Complication, Catheter Complications

In brief

Particulate contamination due to infusion therapy (administration of parenteral nutrition and medications) carries a potential health risk for infants in neonatal intensive care units (NICU). In-line filtration is increasingly used in critically-ill infants but its benefits, by preventing micro-particle infusion in neonates, remain to be demonstrated. In-line filters in the intravenous administration sets prevent the infusion of particles, which may reduce infectious complications.

Key facts

Study ID

NCT05537389

Run by

University of Turin, Italy

People needed

736

Starts

2023-01-01

Expected to finish

2026-06-30

Last updated by the study team

2026-03-30

Who can join

Age: any, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients admitted to NICU with at least one central venous catheter

You may not qualify if…

• Patients with peripheral venous catheter, patients with inflammatory episode at the time of enrollment

Where it is running

• Città della Salute e della Scienza — Torino, Italia, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.